Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Supporto decisionale per adulti che affrontano la sostituzione del generatore di impulsi del defibrillatore cardioverter impiantabile

14 agosto 2026 aggiornato da: Ottawa Heart Institute Research Corporation

Valutazione del supporto decisionale per gli adulti che affrontano la sostituzione del generatore di impulsi del defibrillatore cardioverter impiantabile: uno studio di fattibilità

The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, the investigators developed PDA for ICD replacement. The purpose of this feasibility trial is to collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Eligible and consented participants facing ICD replacement will be randomized to receive the decision aid or to usual care. The investigators will assess if this decision aid can improve participants' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.

Panoramica dello studio

Descrizione dettagliata

Sudden cardiac death (SCD) due to a ventricular arrhythmia is a serious cause of cardiovascular death in Canada. The implantable cardioverter defibrillator (ICD) can reduce the incidence of SCD in high-risk patients by delivering an internal shock to restore a normal rhythm. The life expectancy of an ICD generator is estimated between four and seven years, and must be surgically replaced to ensure ongoing function. Implantable cardioverter-defibrillator (ICD) replacement is becoming increasingly common constituting nearly 40% of all ICD procedures. For the most part, ICDs are automatically replaced. With every ICD replacement, the net benefit of continued ICD therapy should be assessed individually in view of the procedural risks, inappropriate shocks, psychological risks, changes in health status, and the potential for harm and suffering at end-of-life. Some studies have shown that the mortality benefit of an ICD attenuates with advancing age and comorbidities.

There are many legitimate reasons for declining ICD generator replacement. The chronic nature of a cardiac condition and/or the diagnosis of a life-limiting disease since initial implantation may compel a patient to reconsider their health care goals from supporting quantity of life, to prioritizing one of quality. This is an important distinction as the ICD can prolong the dying process by delivering shock(s) which can result in pain and discomfort for the patient, and helplessness for witnesses. Other patients have reported psychological distress, while others report only truly understanding the effects of living with an ICD after receiving one, possibly leading to changes in treatment preference when they are faced with the decision to replace. Also, the replacement procedure includes a substantially greater risk for infection and reoperation as compared to the initial implantation.

These complexities warrant decision support to prepare patients to make decisions. Yet, no means exists to support patients' decision-making in the context of ICD replacement. A decision support intervention (including a patient decision aid with decision coaching) was developed using a user-centered design with various stakeholders and potential end-users, which could moderate treatment related uncertainty and prepare patients to make high quality decisions that are informed and based on their personal preferences and values.

Objectives:

  1. Conduct a pilot randomized controlled trial (RCT) to determine the feasibility of conducting a larger trial.
  2. To determine the effect of the decision support intervention for adults faced with ICD replacement on attributes of decision quality and decision-making processes

Tipo di studio

Interventistico

Iscrizione (Effettivo)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Ontario
      • Ottawa, Ontario, Canada, K1Y 4W7
        • University of Ottawa Heart Institute

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • ICD battery nearing depletion or at elective replacement indicator
  • Able to speak and read in English
  • Able to provide informed consent; or if incapable of providing informed consent, can be obtained by the patient's appointed substitute decision-maker or power of attorney for personal care.

Exclusion Criteria:

  • Participants and/or substitute decision maker unable to understand the patient decision aid or decision coaching session due to language barrier or visual impairment
  • Participants with cardiac resynchronization therapy (CRT) or participants eligible for an upgrade to CRT.
  • Participants with conduction system disease who are pacemaker dependent

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Decision support

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

The decision support intervention includes a patient decision and a decision coaching session. The patient decision aid includes a summary about the ICD's function, and the risks and benefits (including probabilities) associated with the option of replacing or not replacing the ICD. The decision coaching session will be led by a trained, non-directive decision coach who will provide support that aims to develop patients' skills in thinking about the options, assess their values associated with each option, and prepare them to discuss the decision in a consultation with their physician. The final decision, whether to replace or not replace the ICD, will be made with their treating physician (e.g., cardiologist, electrophysiologist).

Nessun intervento: Usual care

The control group will not receive the decision support intervention prior to consultation with the physician.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pilot RCT (Feasibility Measure): Participant Referral/Recruitment Rate.
Lasso di tempo: Baseline to 12 months
Baseline to 12 months
Pilot RCT (Feasibility Measure): Completion of Decision Support Intervention
Lasso di tempo: Baseline to 6 months

In this feasibility RCT, the feasibility regarding key processes to the success of a larger trial will be assessed. The investigators will descriptively collect the rate of participants who complete the decision support intervention.

Baseline to 6 months
Percentage of Participants With Missing Questionnaires
Lasso di tempo: Baseline to 6 months

The percentage of participants with missing questionnaire data is reported.

Baseline to 6 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Knowledge
Lasso di tempo: Measured at 2-4 week Follow Up

The investigators developed a knowledge test based on the content of the patient decision aid. It was endorsed for validity by the Patient Decision Aid (PtDA) development team using a standardized template in the form of true or false questions. There are six questions meant to assess a patient's understanding of their heart condition, treatment options, and risks and benefits of each option. Reported scores are the mean percentage of correctly answered questions from the knowledge based test.

Measured at 2-4 week Follow Up
Decisional Conflict
Lasso di tempo: 1 month, 6 months, 12 months follow-up

The Decisional Conflict Scale measures a person's perception of the difficulty in making a decision, the extent to which they feel uncertain about treatment options, are knowledgeable about the risks and benefits of options, clear about personal values, and supported in decision making. The scale has good test-retest reliability (Cronbach's alpha coefficients > 0.78) and predictive validity.

The scores for each item range from 0-4. The scores for all items are summed, then divided by 16 and multiplied by 25. Total scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

Scores lower than 25 are associated with decision implementation and scores higher than 37.5 are associated with delayed decisions.

1 month, 6 months, 12 months follow-up
Preferred Option
Lasso di tempo: Assessed at 2-4 weeks

Preferred option will be measured by asking patients whether they prefer to have their ICD's pulse generator replaced, not replaced, or whether they are unsure using the 15-point Choice Predisposition Scale that demonstrates a patient's inclination toward a given option. This scale has a test-retest coefficient >0.90.

Score scale 1-15 with lower scores indicating a preference to not replacing the ICD, and high scores toward replacing.

Assessed at 2-4 weeks
Perceptions of Involvement in Decision-making at 6Months
Lasso di tempo: at 6 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 6 month follow up
Perceptions of Involvement in Decision-making at 12Months
Lasso di tempo: at 12 month follow up

This will be measured using a modified version of Strull, Lo, & Charles's (1984) role in decision-making survey. Five statements rest along the continuum of how decisions can be made between patients and providers. Participants must select the statement that best represents their perceived involvement in the final decision.

Results are cumulative across timepoints.

at 12 month follow up
The Medical Outcomes Trust Short Form (SF-36v2)
Lasso di tempo: Baseline visit intervention and usual care groups

The SF-36 is a reliable and valid generic health related quality of life scale (HRQL) comprised of 36 items. Associations between HRQL and decision choice will be made.

Score ranges from 0 to 100. Higher scores indicate better perception of health.

Baseline visit intervention and usual care groups
Acceptability and Usability of Patient Decision Aid
Lasso di tempo: 1 month; intervention group only

Intervention group participants will be asked common acceptability and usability questions extensively used for evaluating PtDAs during development (Barry, Cherkin, Chang, Fowler, & Skates, 1997; Kushniruk & Patel, 2004; O'Connor & Cranney, 2002).

Results are reported as the number of participants selecting the highest acceptability for each category with the most positive answer in parenthesis in the row title.

1 month; intervention group only
Participant Satisfaction With Decision Coaching
Lasso di tempo: 1 month; intervention group only

Patients' satisfaction with decision coaching will be measured using the Genetic Counseling Satisfaction Scale and perceptions of decision coach neutrality (Schwalm, Stacey, Pericak, & Natarajan, 2012; Tercyak, Johnson, Roberts, & Cruz, 2001). This scale has face validity and a reliability coefficient of alpha 0.80 to 0.90 in genetic counselling contexts with adults.

Results are reported as number of participants that rated the highest satisfaction for each question, with the most positive response in parentheses in the row name.

1 month; intervention group only

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Actual Choice at 6months
Lasso di tempo: 6 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement, or decline ICD replacement. Only participants that were required to make a final decision and procedure dates occurred at the 6 month timeline.

6 month followup; intervention and usual care groups
Actual Choice at 12months
Lasso di tempo: 12 month followup; intervention and usual care groups

The number of participants who chose to accept ICD replacement or decline ICD replacement. Results include only those participants required to make a final decision, with procedure dates up to the 12month follow-up. Note that the results at 12months include those at 6months as cumulative data.

12 month followup; intervention and usual care groups
Survival
Lasso di tempo: 6 months, 12 months; intervention and usual care groups14

The number of participants who are alive or dead at 6 months and 12months.

6 months, 12 months; intervention and usual care groups14

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: Dawn Stacey, RN, PhD, University of Ottawa; Ottawa Hospital Research Institute

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 aprile 2016

Completamento primario (Effettivo)

1 aprile 2018

Completamento dello studio (Effettivo)

1 ottobre 2018

Date di iscrizione allo studio

Primo inviato

15 gennaio 2016

Primo inviato che soddisfa i criteri di controllo qualità

26 gennaio 2016

Primo Inserito (Stimato)

29 gennaio 2016

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

9 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 agosto 2026

Ultimo verificato

1 aprile 2022

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi